Cargando…
Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis
BACKGROUND: Anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) is a systemic autoimmune disease characterized by destructive vascular inflammation. Two prominent ANCA autoantigens are myeloperoxidase (MPO) and proteinase 3 (PR3), and transcription of MPO and PRTN3, the genes...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057507/ https://www.ncbi.nlm.nih.gov/pubmed/27752292 http://dx.doi.org/10.1186/s13148-016-0251-0 |
_version_ | 1782459084565381120 |
---|---|
author | Yang, Jiajin Ge, Heng Poulton, Caroline J. Hogan, Susan L. Hu, Yichun Jones, Britta E. Henderson, Candace D. McInnis, Elizabeth A. Pendergraft, William F. Jennette, J. Charles Falk, Ronald J. Ciavatta, Dominic J. |
author_facet | Yang, Jiajin Ge, Heng Poulton, Caroline J. Hogan, Susan L. Hu, Yichun Jones, Britta E. Henderson, Candace D. McInnis, Elizabeth A. Pendergraft, William F. Jennette, J. Charles Falk, Ronald J. Ciavatta, Dominic J. |
author_sort | Yang, Jiajin |
collection | PubMed |
description | BACKGROUND: Anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) is a systemic autoimmune disease characterized by destructive vascular inflammation. Two prominent ANCA autoantigens are myeloperoxidase (MPO) and proteinase 3 (PR3), and transcription of MPO and PRTN3, the genes encoding the autoantigens, is associated with disease activity. We investigated whether patients with AAV have alterations in histone modifications, particularly those associated with transcriptional activation, at MPO and PRTN3. RESULTS: We identified a network of genes regulating histone modifications that were differentially expressed in AAV patients compared to healthy controls. We focused on four genes (EHMT1 and EHMT2, ING4, and MSL1) and found their expression correlated with expression of MPO and PRTN3. Methylation of histone H3K9, catalyzed by EHMT1 and EHMT2 and associated with gene silencing, was most depleted at MPO and PRTN3 in patients with active disease and the highest MPO and PRTN3 expression. Acetylation of histone H4K16, modified by complexes containing ING4 and MSL1 and associated with gene activation, was most enriched at MPO and PRTN3 in patients with active disease and the highest MPO and PRTN3 expression. Methylation at H3K4, a mark of transcriptional activation, was enriched at MPO and PRTN3 in patients and healthy controls. CONCLUSIONS: MPO and PRTN3 in neutrophils of AAV patients with active disease have a distinct pattern of histone modifications, which implicates epigenetic mechanisms in regulating expression of autoantigen genes and suggests that the epigenome may be involved in AAV pathogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-016-0251-0) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5057507 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-50575072016-10-17 Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis Yang, Jiajin Ge, Heng Poulton, Caroline J. Hogan, Susan L. Hu, Yichun Jones, Britta E. Henderson, Candace D. McInnis, Elizabeth A. Pendergraft, William F. Jennette, J. Charles Falk, Ronald J. Ciavatta, Dominic J. Clin Epigenetics Research BACKGROUND: Anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) is a systemic autoimmune disease characterized by destructive vascular inflammation. Two prominent ANCA autoantigens are myeloperoxidase (MPO) and proteinase 3 (PR3), and transcription of MPO and PRTN3, the genes encoding the autoantigens, is associated with disease activity. We investigated whether patients with AAV have alterations in histone modifications, particularly those associated with transcriptional activation, at MPO and PRTN3. RESULTS: We identified a network of genes regulating histone modifications that were differentially expressed in AAV patients compared to healthy controls. We focused on four genes (EHMT1 and EHMT2, ING4, and MSL1) and found their expression correlated with expression of MPO and PRTN3. Methylation of histone H3K9, catalyzed by EHMT1 and EHMT2 and associated with gene silencing, was most depleted at MPO and PRTN3 in patients with active disease and the highest MPO and PRTN3 expression. Acetylation of histone H4K16, modified by complexes containing ING4 and MSL1 and associated with gene activation, was most enriched at MPO and PRTN3 in patients with active disease and the highest MPO and PRTN3 expression. Methylation at H3K4, a mark of transcriptional activation, was enriched at MPO and PRTN3 in patients and healthy controls. CONCLUSIONS: MPO and PRTN3 in neutrophils of AAV patients with active disease have a distinct pattern of histone modifications, which implicates epigenetic mechanisms in regulating expression of autoantigen genes and suggests that the epigenome may be involved in AAV pathogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-016-0251-0) contains supplementary material, which is available to authorized users. BioMed Central 2016-08-12 /pmc/articles/PMC5057507/ /pubmed/27752292 http://dx.doi.org/10.1186/s13148-016-0251-0 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Yang, Jiajin Ge, Heng Poulton, Caroline J. Hogan, Susan L. Hu, Yichun Jones, Britta E. Henderson, Candace D. McInnis, Elizabeth A. Pendergraft, William F. Jennette, J. Charles Falk, Ronald J. Ciavatta, Dominic J. Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis |
title | Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis |
title_full | Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis |
title_fullStr | Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis |
title_full_unstemmed | Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis |
title_short | Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis |
title_sort | histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057507/ https://www.ncbi.nlm.nih.gov/pubmed/27752292 http://dx.doi.org/10.1186/s13148-016-0251-0 |
work_keys_str_mv | AT yangjiajin histonemodificationsignatureatmyeloperoxidaseandproteinase3inpatientswithantineutrophilcytoplasmicautoantibodyassociatedvasculitis AT geheng histonemodificationsignatureatmyeloperoxidaseandproteinase3inpatientswithantineutrophilcytoplasmicautoantibodyassociatedvasculitis AT poultoncarolinej histonemodificationsignatureatmyeloperoxidaseandproteinase3inpatientswithantineutrophilcytoplasmicautoantibodyassociatedvasculitis AT hogansusanl histonemodificationsignatureatmyeloperoxidaseandproteinase3inpatientswithantineutrophilcytoplasmicautoantibodyassociatedvasculitis AT huyichun histonemodificationsignatureatmyeloperoxidaseandproteinase3inpatientswithantineutrophilcytoplasmicautoantibodyassociatedvasculitis AT jonesbrittae histonemodificationsignatureatmyeloperoxidaseandproteinase3inpatientswithantineutrophilcytoplasmicautoantibodyassociatedvasculitis AT hendersoncandaced histonemodificationsignatureatmyeloperoxidaseandproteinase3inpatientswithantineutrophilcytoplasmicautoantibodyassociatedvasculitis AT mcinniselizabetha histonemodificationsignatureatmyeloperoxidaseandproteinase3inpatientswithantineutrophilcytoplasmicautoantibodyassociatedvasculitis AT pendergraftwilliamf histonemodificationsignatureatmyeloperoxidaseandproteinase3inpatientswithantineutrophilcytoplasmicautoantibodyassociatedvasculitis AT jennettejcharles histonemodificationsignatureatmyeloperoxidaseandproteinase3inpatientswithantineutrophilcytoplasmicautoantibodyassociatedvasculitis AT falkronaldj histonemodificationsignatureatmyeloperoxidaseandproteinase3inpatientswithantineutrophilcytoplasmicautoantibodyassociatedvasculitis AT ciavattadominicj histonemodificationsignatureatmyeloperoxidaseandproteinase3inpatientswithantineutrophilcytoplasmicautoantibodyassociatedvasculitis |